Annual Net Income
$998.37 M
-$1.35 B-57.47%
March 31, 2024
Summary
- As of February 26, 2025, TAK annual net profit is $998.37 million, with the most recent change of -$1.35 billion (-57.47%) on March 31, 2024.
- During the last 3 years, TAK annual net income has fallen by -$2.55 billion (-71.85%).
- TAK annual net income is now -71.85% below its all-time high of $3.55 billion, reached on March 31, 2021.
Performance
TAK Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
$155.96 M
-$463.73 M-74.83%
December 1, 2024
Summary
- As of February 26, 2025, TAK quarterly net profit is $155.96 million, with the most recent change of -$463.73 million (-74.83%) on December 1, 2024.
- Over the past year, TAK quarterly net income has stayed the same.
- TAK quarterly net income is now -91.62% below its all-time high of $1.86 billion, reached on March 31, 2021.
Performance
TAK Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
$1.37 B
-$560.04 M-29.07%
December 1, 2024
Summary
- As of February 26, 2025, TAK TTM net profit is $1.37 billion, with the most recent change of -$560.04 million (-29.07%) on December 1, 2024.
- Over the past year, TAK TTM net income has stayed the same.
- TAK TTM net income is now -69.09% below its all-time high of $4.42 billion, reached on September 30, 2021.
Performance
TAK TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
TAK Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -57.5% | 0.0% | 0.0% |
| 3 y3 years | -71.8% | 0.0% | 0.0% |
| 5 y5 years | -18.1% | 0.0% | 0.0% |
TAK Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -71.8% | at low | -81.5% | +146.9% | -66.2% | +40.3% |
| 5 y | 5-year | -71.8% | +145.3% | -91.6% | +146.9% | -69.1% | +924.5% |
| alltime | all time | -71.8% | +174.9% | -91.6% | +108.2% | -69.1% | +206.2% |
Takeda Pharmaceutical Company Limited Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $155.96 M(-74.8%) | $1.37 B(-29.1%) |
| Sep 2024 | - | $619.69 M(+1.4%) | $1.93 B(+97.7%) |
| Jun 2024 | - | $611.00 M(-3104.7%) | $974.15 M(-4.0%) |
| Mar 2024 | $998.37 M(-57.5%) | -$20.33 M(-102.8%) | $1.01 B(-20.2%) |
| Dec 2023 | - | $716.00 M(-315.3%) | $1.27 B(-9.2%) |
| Sep 2023 | - | -$332.51 M(-151.0%) | $1.40 B(-35.8%) |
| Jun 2023 | - | $651.48 M(+176.4%) | $2.18 B(-6.8%) |
| Mar 2023 | $2.35 B(+14.6%) | $235.71 M(-72.1%) | $2.34 B(+16.6%) |
| Dec 2022 | - | $844.99 M(+89.1%) | $2.00 B(+20.2%) |
| Sep 2022 | - | $446.94 M(-44.9%) | $1.67 B(+1.8%) |
| Jun 2022 | - | $810.45 M(-929.0%) | $1.64 B(-21.4%) |
| Mar 2022 | $2.05 B(-42.2%) | -$97.77 M(-119.2%) | $2.09 B(-48.4%) |
| Dec 2021 | - | $508.19 M(+21.7%) | $4.04 B(-8.5%) |
| Sep 2021 | - | $417.60 M(-66.8%) | $4.42 B(+9.4%) |
| Jun 2021 | - | $1.26 B(-32.4%) | $4.04 B(+13.8%) |
| Mar 2021 | $3.55 B(+771.4%) | $1.86 B(+110.4%) | $3.55 B(+108.2%) |
| Dec 2020 | - | $884.32 M(+2224.8%) | $1.70 B(+225.2%) |
| Sep 2020 | - | $38.04 M(-95.0%) | $524.31 M(-53.1%) |
| Jun 2020 | - | $766.76 M(+4743.6%) | $1.12 B(+169.5%) |
| Mar 2020 | $407.05 M(-66.6%) | $15.83 M(-105.3%) | $414.73 M(+211.0%) |
| Dec 2019 | - | -$296.32 M(-146.9%) | $133.36 M(-82.6%) |
| Sep 2019 | - | $631.45 M(+890.2%) | $764.66 M(+34.7%) |
| Jun 2019 | - | $63.77 M(-124.0%) | $567.68 M(-53.5%) |
| Mar 2019 | $1.22 B(-27.7%) | -$265.54 M(-179.3%) | $1.22 B(+23.6%) |
| Dec 2018 | - | $334.98 M(-22.9%) | $988.47 M(-21.3%) |
| Sep 2018 | - | $434.46 M(-39.4%) | $1.26 B(+16.9%) |
| Jun 2018 | - | $717.36 M(-243.9%) | $1.07 B(-35.3%) |
| Mar 2018 | $1.69 B(+58.7%) | -$498.34 M(-182.7%) | $1.66 B(-3.0%) |
| Dec 2017 | - | $602.88 M(+138.6%) | $1.71 B(+15.0%) |
| Sep 2017 | - | $252.69 M(-80.6%) | $1.49 B(+0.7%) |
| Jun 2017 | - | $1.30 B(-392.1%) | $1.48 B(+34.8%) |
| Mar 2017 | $1.06 B(+59.1%) | -$446.18 M(-217.7%) | $1.10 B(-12.4%) |
| Dec 2016 | - | $379.13 M(+56.6%) | $1.25 B(-8.0%) |
| Sep 2016 | - | $242.03 M(-73.7%) | $1.36 B(-0.1%) |
| Jun 2016 | - | $921.53 M(-417.1%) | $1.36 B(+111.7%) |
| Mar 2016 | $668.06 M | -$290.57 M(-159.6%) | $643.85 M(-167.2%) |
| Dec 2015 | - | $487.84 M(+100.0%) | -$958.34 M(-25.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | $243.92 M(+20.4%) | -$1.29 B(+2.0%) |
| Jun 2015 | - | $202.66 M(-110.7%) | -$1.26 B(+10.9%) |
| Mar 2015 | -$1.33 B(-225.2%) | -$1.89 B(-1282.3%) | -$1.14 B(-328.1%) |
| Dec 2014 | - | $160.09 M(-40.7%) | $497.98 M(-43.5%) |
| Sep 2014 | - | $269.75 M(-17.5%) | $880.89 M(-15.6%) |
| Jun 2014 | - | $326.95 M(-226.3%) | $1.04 B(-3.4%) |
| Mar 2014 | $1.06 B(-40.8%) | -$258.81 M(-147.7%) | $1.08 B(-25.2%) |
| Dec 2013 | - | $543.00 M(+25.4%) | $1.44 B(+27.0%) |
| Sep 2013 | - | $432.93 M(+18.9%) | $1.14 B(+2.1%) |
| Jun 2013 | - | $363.96 M(+246.6%) | $1.11 B(-39.5%) |
| Mar 2013 | $1.80 B(+14.3%) | $105.01 M(-55.4%) | $1.84 B(+44.2%) |
| Dec 2012 | - | $235.50 M(-42.5%) | $1.28 B(-6.4%) |
| Sep 2012 | - | $409.84 M(-62.5%) | $1.36 B(-21.0%) |
| Jun 2012 | - | $1.09 B(-337.4%) | $1.73 B(+10.6%) |
| Mar 2012 | $1.57 B(-45.4%) | -$460.05 M(-242.7%) | $1.56 B(-35.3%) |
| Dec 2011 | - | $322.37 M(-58.3%) | $2.42 B(-18.3%) |
| Sep 2011 | - | $772.91 M(-16.6%) | $2.96 B(-5.1%) |
| Jun 2011 | - | $926.65 M(+135.4%) | $3.12 B(+8.0%) |
| Mar 2011 | $2.88 B(-10.3%) | $393.59 M(-54.4%) | $2.89 B(-1.1%) |
| Dec 2010 | - | $863.04 M(-7.4%) | $2.92 B(+3.2%) |
| Sep 2010 | - | $931.84 M(+33.8%) | $2.83 B(+4.0%) |
| Jun 2010 | - | $696.69 M(+63.8%) | $2.72 B(-14.4%) |
| Mar 2010 | $3.21 B(+36.1%) | $425.27 M(-45.0%) | $3.18 B(-8.1%) |
| Dec 2009 | - | $773.75 M(-6.1%) | $3.46 B(-6.4%) |
| Sep 2009 | - | $824.17 M(-28.7%) | $3.70 B(+5.0%) |
| Jun 2009 | - | $1.16 B(+64.2%) | $3.52 B(+48.9%) |
| Mar 2009 | $2.36 B(-24.4%) | $703.69 M(-30.4%) | $2.36 B(+42.4%) |
| Dec 2008 | - | $1.01 B(+56.3%) | $1.66 B(+156.3%) |
| Sep 2008 | - | $647.15 M | $647.15 M |
| Mar 2008 | $3.12 B(+8.6%) | - | - |
| Mar 2007 | $2.87 B(+3.7%) | - | - |
| Mar 2006 | $2.77 B(+7.2%) | - | - |
| Mar 2005 | $2.59 B(+2.1%) | - | - |
| Mar 2004 | $2.53 B(+13.4%) | - | - |
| Mar 2003 | $2.23 B(+18.3%) | - | - |
| Mar 2002 | $1.89 B(+41.8%) | - | - |
| Mar 2001 | $1.33 B(+23.4%) | - | - |
| Mar 2000 | $1.08 B | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual net profit?
- What is the all time high annual net income for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual net income year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly net profit?
- What is the all time high quarterly net income for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly net income year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM net profit?
- What is the all time high TTM net income for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM net income year-on-year change?
What is Takeda Pharmaceutical Company Limited annual net profit?
The current annual net income of TAK is $998.37 M
What is the all time high annual net income for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual net profit is $3.55 B
What is Takeda Pharmaceutical Company Limited annual net income year-on-year change?
Over the past year, TAK annual net profit has changed by -$1.35 B (-57.47%)
What is Takeda Pharmaceutical Company Limited quarterly net profit?
The current quarterly net income of TAK is $155.96 M
What is the all time high quarterly net income for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly net profit is $1.86 B
What is Takeda Pharmaceutical Company Limited quarterly net income year-on-year change?
Over the past year, TAK quarterly net profit has changed by $0.00 (0.00%)
What is Takeda Pharmaceutical Company Limited TTM net profit?
The current TTM net income of TAK is $1.37 B
What is the all time high TTM net income for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM net profit is $4.42 B
What is Takeda Pharmaceutical Company Limited TTM net income year-on-year change?
Over the past year, TAK TTM net profit has changed by $0.00 (0.00%)